News
Australia’s Publicly Funded Vaccines Market
1 December 2010
The OHE recently published reports on the vaccines markets in Australia and in the UK, originally prepared as case studies for a project funded by the…
Prof Devlin Elected Chair of EuroQol Group
25 November 2010
OHE is pleased to announce that Professor Nancy Devlin, Director of Research, has been elected as Chair of the EuroQol Group’s executive committee, effective as from…
The UK’s Publicly Funded Vaccines Market
23 November 2010
The OHE has just published reports on the vaccines markets in Australia and in the UK, originally prepared as case studies for a project funded by…
Annual Lecture Publication Now Available
16 November 2010
Now available is the full text of Dr Alan Garber’s remarks at the OHE Annual Lecture. Each year, the OHE sponsors a lecture that explores a…
Disease severity and public preferences
4 November 2010
Does including the name of a specific severe disease in preference surveys affect public attitudes toward resource allocation? A recent proof of concept study suggests that…
The Impact of Science Policy Research
27 October 2010
Science, technology and innovation (STI) are gaining even greater importance with globalisation and international competition. The benefits STI provides, however, also carry risks and social costs.…
Access to Orphan Drugs in the EU
21 October 2010
Legislation in the EU provides incentives for the developmeng of drugs for rare diseases, known as orphan medicinal products (OMPs). At a recent conference, OHE’s Dr…
Biomedical and Health Research Spillovers in the UK
14 October 2010
Research spillovers exist when research by one organisation creates increased output for other organisations that operate in the same or other sector of the economy. Given…
New Antimicrobial Drugs: EU Policy Options
4 October 2010
Antimicrobial resistance to drugs is a growing global public health issue. The EU began a discussion in 2009 about which policies can best encourage the development…